Two Sisters with Colchicine-Resistant form of Familial Mediterranean Fever on the Canakinumab Therapy: Clinical Case
Background. Colchicine-resistant cases of familial Mediterranean fever (FMF) are associated with high risk of kidney amyloidosis and severe episodes of the disease with pyretic fever, arthritis, pleurisies, pericarditis. It is difficult to achieve disease control in colchicine-resistant patients and...
Main Authors: | Elena A. Ligostaeva, Nadezhda A. Tsurikova, Irina A. Tsiganok, Nataliya N. Kobzeva, Vadim Yu. Avdeenko |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2020-01-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/2234 |
Similar Items
-
Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases
by: Mustafa Çakan, et al.
Published: (2020-04-01) -
Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
by: Burcu Bozkaya Yücel, et al.
Published: (2021-09-01) -
Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever
by: Ali Şahin, et al.
Published: (2020-01-01) -
Familial Mediterranean Fever: an unusual cause of liver disease
by: Maria Cristina Maggio, et al.
Published: (2019-09-01) -
Familial Mediterranean fever (periodic disease): history or a real problem
by: E. S. Fedorov, et al.
Published: (2018-09-01)